Emcure Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Emcure Pharmaceuticals conducted a Postal Ballot via remote e-voting from February 19 to March 20, 2026, seeking shareholder approval on three special resolutions. All three resolutions were passed with overwhelming majority: re-appointment of Mr. Vijay Keshav Gokhale as Independent Director was approved with 99.83% votes in favour (15.52 crore shares), re-appointment of Dr. Vidya Rajiv Yeravdekar was approved with 93.90% in favour (14.56 crore shares), and re-appointment of Dr. Shailesh Kripalu Ayyangar was approved with 97.06% in favour (15.05 crore shares). The promoter group, holding 14.76 crore shares, voted 100% in favour of all three resolutions. Total voting turnout was strong at approximately 82% of outstanding shares, with the Scrutinizer confirming the process was fair and transparent.
The smooth approval of all three Independent Director re-appointments ensures continuity on Emcure's board with no disruption to corporate governance. The high voting turnout (82%) and near-unanimous support reflect strong shareholder confidence in the current board composition, with no material negative signal for the stock.